Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250118064423N1Phase 3Completed
Phase 3, randomised, double-blind trial comparing Midazolam premedication with Placebo premedication (2 arms). Primary endpoints: Shivering, Tremor and 3 more. Started Jul 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250118064423N1.